{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:49:33Z","timestamp":1791942573652,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016469","name":"Takeda Pharmaceuticals International AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016469","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic and Interventional Imaging"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.diii.2025.02.002","type":"journal-article","created":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T03:55:06Z","timestamp":1740282906000},"page":"247-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cardiac magnetic resonance imaging in the follow-up of patients with Fabry cardiomyopathy"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3018-6784","authenticated-orcid":false,"given":"Jules","family":"Senlis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4435-4401","authenticated-orcid":false,"given":"Fabien","family":"Labombarda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8726-265X","authenticated-orcid":false,"given":"Julien","family":"Burel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6457-4368","authenticated-orcid":false,"given":"Arthur","family":"Flouriot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Normant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9525-2387","authenticated-orcid":false,"given":"Matthieu","family":"Demeyere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8141-6582","authenticated-orcid":false,"given":"Olivier","family":"Lairez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraya El","family":"Ghannudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Jacquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9229-9489","authenticated-orcid":false,"given":"Olivier","family":"Ghekiere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Cadour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7681-5252","authenticated-orcid":false,"given":"Jean-Nicolas","family":"Dacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diii.2025.02.002_bib0001","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.diii.2025.02.002_bib0002","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/GIM.0b013e3181bb05bb","article-title":"Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry registry","volume":"11","author":"Waldek","year":"2009","journal-title":"Genet Med"},{"key":"10.1016\/j.diii.2025.02.002_bib0003","first-page":"f153","article-title":"Ventricular arrhythmia and sudden cardiac death in Fabry disease: a systematic review of risk factors in clinical practice","volume":"20","author":"Baig","year":"2018","journal-title":"EP Eur"},{"key":"10.1016\/j.diii.2025.02.002_bib0004","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.amjcard.2014.06.019","article-title":"Relation of burden of myocardial fibrosis to malignant ventricular arrhythmias and outcomes in Fabry Disease","volume":"114","author":"Kr\u00e4mer","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.diii.2025.02.002_bib0005","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.diii.2025.02.002_bib0006","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human \u03b1-galactosidase: a replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diii.2025.02.002_bib0007","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa1510198","article-title":"Treatment of Fabry's disease with the pharmacologic chaperone migalastat","volume":"375","author":"Germain","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diii.2025.02.002_bib0008","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.diii.2024.08.002","article-title":"Diagnostic performance and relationships of structural parameters and strain components for the diagnosis of cardiac amyloidosis with MRI","volume":"105","author":"Zaarour","year":"2024","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.diii.2025.02.002_bib0009","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.diii.2024.09.007","article-title":"Myocardial strain imaging: advancing the diagnosis of cardiac amyloidosis with MRI","volume":"105","author":"Krumm","year":"2024","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.diii.2025.02.002_bib0010","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.diii.2023.07.005","article-title":"T2* map at cardiac MRI reveals incidental hepatic and cardiac iron overload","volume":"104","author":"Brendel","year":"2023","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.diii.2025.02.002_bib0011","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCIMAGING.112.000070","article-title":"Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping","volume":"6","author":"Sado","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.diii.2025.02.002_bib0012","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/CIRCIMAGING.113.000482","article-title":"T\u2081 mapping with cardiovascular MRI is highly sensitive for Fabry disease independent of hypertrophy and sex","volume":"6","author":"Thompson","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.diii.2025.02.002_bib0013","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.diii.2019.08.006","article-title":"Differentiation between Fabry disease and hypertrophic cardiomyopathy with cardiac T1 mapping","volume":"101","author":"Deborde","year":"2020","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.diii.2025.02.002_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.877364","article-title":"Role of cardiovascular magnetic resonance to assess cardiovascular inflammation","volume":"9","author":"Filomena","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.diii.2025.02.002_bib0015","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/ehjci\/jeaa101","article-title":"The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage","volume":"22","author":"Augusto","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.diii.2025.02.002_bib0016","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.crad.2016.02.013","article-title":"Assessment of myocardial fibrosis with T1 mapping MRI","volume":"71","author":"Everett","year":"2016","journal-title":"Clin Radiol"},{"key":"10.1016\/j.diii.2025.02.002_bib0017","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.009430","article-title":"Myocardial storage, inflammation, and cardiac phenotype in Fabry disease after one year of enzyme replacement therapy","volume":"12","author":"Nordin","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.diii.2025.02.002_bib0018","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","volume":"19","author":"Messroghli","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.diii.2025.02.002_bib0019","article-title":"An introductory guide to statistics for the radiologist","author":"O'Shaughnessy","year":"2024","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.diii.2025.02.002_bib0021","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.carpath.2009.05.003","article-title":"A detailed pathologic examination of heart tissue from three older patients with Anderson-Fabry disease on enzyme replacement therapy","volume":"19","author":"Sheppard","year":"2010","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.diii.2025.02.002_bib0022","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/eurheartj\/ehac719","article-title":"Fatty infiltration of inferolateral left ventricular wall in Fabry disease","volume":"44","author":"Soulat","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diii.2025.02.002_bib0023","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.jacc.2016.07.741","article-title":"Cardiac Fabry disease with late gadolinium enhancement is a chronic inflammatory cardiomyopathy","volume":"68","author":"Nordin","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diii.2025.02.002_bib0024","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1148\/radiol.2019191385","article-title":"Left ventricular hypertrophy and late gadolinium enhancement at cardiac MRI are associated with adverse cardiac events in Fabry disease","volume":"294","author":"Hanneman","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.diii.2025.02.002_bib0025","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1136\/heartjnl-2012-302346","article-title":"Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease","volume":"98","author":"Sado","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.diii.2025.02.002_bib0026","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1532-429X-14-28","article-title":"Cardiovascular magnetic resonance in systemic hypertension","volume":"14","author":"Maceira","year":"2012","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.diii.2025.02.002_bib0027","doi-asserted-by":"crossref","first-page":"qyae094","DOI":"10.1093\/ehjimp\/qyae094","article-title":"Quality control of cardiac magnetic resonance, imaging segmentation, feature tracking, aortic flow and native T1 analysis using automated batch processing in the UK Biobank study","volume":"2","author":"Chadalavada","year":"2024","journal-title":"Eur Heart J Imaging Method Pract"},{"key":"10.1016\/j.diii.2025.02.002_bib0028","unstructured":"Germain D.P. Protocole National de Diagnostic et de Soins (PNDS) - Maladie de Fabry 2021. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2021-11\/pnds_de_la_maladie_de_fabry_-_version_finale_-_20211115.pdf."},{"key":"10.1016\/j.diii.2025.02.002_bib0029","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/ckj\/sfw082","article-title":"FAbry STabilization indEX (FASTEX): an innovative tool for the assessment of clinical stabilization in Fabry disease","volume":"9","author":"Mignani","year":"2016","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.diii.2025.02.002_bib0030","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","volume":"105","author":"Cerqueira","year":"2002","journal-title":"Circulation"}],"container-title":["Diagnostic and Interventional Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211568425000087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211568425000087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T19:44:59Z","timestamp":1751399099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211568425000087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":29,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2211568425000087"],"URL":"https:\/\/doi.org\/10.1016\/j.diii.2025.02.002","relation":{},"ISSN":["2211-5684"],"issn-type":[{"value":"2211-5684","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac magnetic resonance imaging in the follow-up of patients with Fabry cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Diagnostic and Interventional Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diii.2025.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de radiologie.","name":"copyright","label":"Copyright"}]}}